|
N.V. Dobrova
NEW POTENTIALS FOR THE USE OF TARGETED THERAPY IN THE TREATMENT OF SOME SOLID TUMORS (BASED ON ESMO 2014)
|
№17 / 2014
|
|
N.N. Semenov
BONDRONAT – THE EXPERIENCE OF USE IN PATIENTS WITH BONE METASTASIS FROM BREAST CANCER
|
№8 / 2014
|
|
M.V. Zabelin (1, 2), DB Sidorov (1, 2), A.S. Safonov (1)
ROLE OF LIPOSUCTION IN THE TREATMENT OF POSTMASTECTOMIC LYMPHEDEMA
|
№8 / 2014
|
|
V.A. Gorbunova
EVEROLIMUS (AFINITOR): NEW POTENTIALS FOR THE THERAPY OF MALIGNANT TUMORS
|
№8 / 2014
|
|
V.A. Gorbunova
PROMISING NEW DRUGS FOR THE TREATMENT OF HER2-POSITIVE BREAST CANCER
|
№8 / 2014
|
|
Yu.Yu. Andreeva, L.E. Zavalishina, N.V. Danilova, M.E. Ilatovskaya, G.A. Frank
METHODOLOGICAL ASPECTS OF MORPHOLOGICAL DIAGNOSIS AND EVALUATION OF THERAPEUTIC PATHOMORPHOSIS OF TRIPLE NEGATIVE BREAST CANCER
|
№8 / 2014
|
|
G.A. Dashyan (1), V.F. Semiglazov (1), E.E. Topuzov (2), V.G. Ivanov (1), V.V. Vorotnikov (1), I.A. Lalak (3), Zh.V. Bryantseva (2), M.V. Usungvan (2), A.I. Tseluyko (1)
BREAST CANCER AND PREGNANCY
|
№4 / 2014
|
|
M.B. Stenina
ERIBULIN - NEW MICROTUBULE INHIBITOR FOR THE TREATMENT OF METASTATIC BREAST CANCER
|
№17 / 2013
|
|
O.V. Salafet 1, T.V. Chernovskaya 1 , L.P. Sheveleva 2 , A.V. Khorinko 3 , T.I. Prokopenko3, M.N. Nechayeva 4, O.N. Burdayeva 4 , M.P. Matrosova 5, N.V. Kovalenko 6 , I.A. Koroleva7, R.A. Ivanov 1
EFFICACY AND SAFETY OF EXTIMIA®, A NEW PEGYLATED FILGRASTIM: RESULTS OF OPEN COMPARATIVE PHASE II CLINICAL TRIAL IN PATIENTS WITH BREAST CANCER RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY
|
№17 / 2013
|
|
N.N. Semenov
THE USE OF BISPHOSPHONATES FOR THE PREVENTION OF BONE METASTASES IN BREAST CANCER PATIENTS
|
№8 / 2013
|
|
V.F.Semiglazov, G.A.Dashyan, T.Yu.Semiglazova, R. M. Paltuyev, K.Yu.Zernov, K.D.Penkov, I.A.Grechukhina, V. V. Semiglazov
THE ROLE OF IMMUNOCONJUGATES IN TARGETED THERAPY OF MALIGNAT TUMORS
|
№8 / 2013
|
|
V.F. Semiglazov, V.V. Semiglazov
FOUR ASPECTS OF ADJUVANT TARGETED THERAPY OF HER2-POSITIVE BREAST CANCER
|
№8 / 2013
|
Русский
